Cargando…
X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective
X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoproliferative syndrome associated with infection with Epstein–Barr virus (EBV). Features include hemophagocytic lymphohistiocytosis (HLH), lymphomas, and dysgammaglobulinemias. Molecular cloning of the causa...
Autores principales: | Panchal, Neelam, Booth, Claire, Cannons, Jennifer L., Schwartzberg, Pamela L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893764/ https://www.ncbi.nlm.nih.gov/pubmed/29670631 http://dx.doi.org/10.3389/fimmu.2018.00666 |
Ejemplares similares
-
Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease
por: Panchal, Neelam, et al.
Publicado: (2018) -
The Road Less Taken: Less Appreciated Pathways for Manipulating CD8(+) T Cell Exhaustion
por: Pichler, Andrea C., et al.
Publicado: (2022) -
Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8(+) T Cell Survival, Differentiation, and Function
por: Cannons, Jennifer L., et al.
Publicado: (2018) -
PI3K Orchestrates T Follicular Helper Cell Differentiation in a Context Dependent Manner: Implications for Autoimmunity
por: Preite, Silvia, et al.
Publicado: (2019) -
Different Phenotypic Presentations of X-Linked Lymphoproliferative Disease in Siblings with Identical Mutations
por: Nademi, Zohreh, et al.
Publicado: (2019)